Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

November 22, 2022

Study Completion Date

January 10, 2023

Conditions

Healthy

Interventions

DRUG

Bravamax 200 mg (Modafinil)

Test drug

DRUG

Vigil 200 mg (Modafinil)

Reference drug

Trial Locations (1)

Genuine Research Center GRC, Cairo